DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer
暂无分享,去创建一个
Ishtiaq Rehman | Simon S Cross | Freddie C Hamdy | James W F Catto | S. Cross | F. Hamdy | J. Catto | A. Leiblich | I. Rehman | Amin Goodarzi | Aaron Leiblich | Joshua T Phillips | J. Phillips | Amin Goodarzi
[1] Rajvir Dahiya,et al. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. , 2005, Journal of the National Cancer Institute.
[2] T. Tkatch,et al. Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation. , 1995, Biochimica et biophysica acta.
[3] L. Mazzucchelli. Protein S100A4: too long overlooked by pathologists? , 2002, The American journal of pathology.
[4] J. Rees,et al. Genetic change in actinic keratoses. , 1996, Oncogene.
[5] O. Witte,et al. S100A5: a marker of recurrence in WHO grade I meningiomas , 2004, Neuropathology and applied neurobiology.
[6] P. Rudland,et al. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. , 1993, Oncogene.
[7] S. Cross,et al. Promoter hyper‐methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer , 2005, The Prostate.
[8] D. Neal,et al. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer , 2002, The Journal of pathology.
[9] P. Rudland,et al. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis , 2004, British Journal of Cancer.
[10] Tajamul Hussain,et al. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] F. Rehman,et al. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity , 2004, British Journal of Cancer.
[12] C. Heizmann,et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] T. Fujiyoshi,et al. Cloning of the sequences expressed abundantly in established cell lines: identification of a cDNA clone highly homologous to S-100, a calcium binding protein. , 1988, Journal of biochemistry.
[14] S. Cross,et al. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. , 2004, Human pathology.
[15] C. Heizmann,et al. The S100 family of EF-hand calcium-binding proteins: functions and pathology. , 1996, Trends in biochemical sciences.
[16] J. Winstanley,et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. , 2000, Cancer research.
[17] C. Heizmann,et al. S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.
[18] J. Issa. CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.
[19] S. Cross,et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors , 2004, British Journal of Cancer.
[20] S. Cross,et al. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers , 2005, Histopathology.
[21] Yohko Nakamura,et al. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells , 1997, Oncogene.
[22] H. Kreipe,et al. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. , 2002, Gastroenterology.
[23] D. Helfman,et al. The metastasis associated protein S100A4: role in tumour progression and metastasis , 2005, British Journal of Cancer.
[24] M. Grigorian,et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.
[25] C. Iacobuzio-Donahue,et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. , 2003, Cancer research.
[26] B. B. Mukherjee,et al. Transformation of normal rat kidney cells by v-K-ras enhances expression of transin 2 and an S-100-related calcium-binding protein. , 1992, Oncogene.
[27] P. Rudland,et al. Differential Reactivity of the RatS100A4(p9Ka) Gene to Sodium Bisulfite Is Associated with Differential Levels of the S100A4 (p9Ka) mRNA in Rat Mammary Epithelial Cells* , 1999, The Journal of Biological Chemistry.
[28] R. Donato,et al. Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.
[29] Naoko Nakamura,et al. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines , 1998, Clinical & Experimental Metastasis.
[30] J. Cameron,et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. , 2002, The American journal of pathology.